1. Home
  2. companies
  3. Teva Pharmaceuticals

Teva Pharmaceuticals

U.S. Supreme Court rules for Teva in over multiple sclerosis drug patent
U.S. Supreme Court rules for Teva in over multiple sclerosis drug patent
Yahoo/Reuters
Teva Pharmaceuticals
Supreme Court
Copaxone
patents
MS
multiple sclerosis
FDA clears pediatric formulation of Teva hay fever med
FDA clears pediatric formulation of Teva hay fever med
Seeking Alpha
FDA
hay fever
Teva Pharmaceuticals
QNASL
Teva Pharmaceutical Releases 2015 Guidance, Sees Increased Generic Competition
Teva Pharmaceutical Releases 2015 Guidance, Sees Increased Generic Competition
Yahoo/Benzinga
Teva Pharmaceuticals
Teva recalls Parkinson's disease drug because it may be 'superpotent'
Teva recalls Parkinson's disease drug because it may be 'superpotent'
Fierce Pharma Manufacturing
Teva Pharmaceuticals
Parkinson's Disease
carbidopa/levodopa
Teva Isn't Moving, for Now, If the Israeli Government Hikes Taxes
Teva Isn't Moving, for Now, If the Israeli Government Hikes Taxes
TheStreet.com
Israel
Teva Pharmaceuticals
Why Teva's Magic Bullet Could Misfire
Why Teva's Magic Bullet Could Misfire
Motley Fool
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Teva's Nuvigil Patent Infringement Lawsuits Resolved
Teva's Nuvigil Patent Infringement Lawsuits Resolved
Yahoo/Zacks.com
NUVIGIL
patents
Teva Pharmaceuticals
Sandoz
Apotex
Mylan Labs
Actavis
Lupin
Teva Pharm's chairman Phillip Frost to step down by year end
Teva Pharm's chairman Phillip Frost to step down by year end
Yahoo/Reuters
Teva Pharmaceuticals
Phillip Frost
Cipla’s Drug Pipeline Makes It $10 Billion Prey: Real M&A
Cipla’s Drug Pipeline Makes It $10 Billion Prey: Real M&A
Bloomberg
Cipla
M&A
India
Mylan
Teva Pharmaceuticals
Bristol-Myers hepatitis B drug patent ruled invalid by appeals court
Bristol-Myers hepatitis B drug patent ruled invalid by appeals court
Yahoo/Fly on the Wall
hepatitis B
Bristol-Myers Squibb
Teva Pharmaceuticals
patents
Teva CFO eyes small US acquisitions
Teva CFO eyes small US acquisitions
Globes, Israel
Teva Pharmaceuticals
M&A
AstraZeneca: Pfizer Wants It, So Should You
AstraZeneca: Pfizer Wants It, So Should You
Seeking Alpha
Pfizer
AstraZeneca
Novartis
Teva Pharmaceuticals
M&A
Teva Pharma to build pain treatment portfolio with $200M deal for Labrys Biologics
Teva Pharma to build pain treatment portfolio with $200M deal for Labrys Biologics
Yahoo/AP
Teva Pharmaceuticals
Labrys
M&A
Chicago Accuses Drug Companies of Pushing Opioids
Chicago Accuses Drug Companies of Pushing Opioids
Bloomberg
chicago
opioids
JNJ
Purdue Pharma
Teva Pharmaceuticals
Actavis
Teva acquisition a positive for Amgen, says Piper Jaffray
Teva acquisition a positive for Amgen, says Piper Jaffray
Yahoo/Fly on the Wall
Teva Pharmaceuticals
Amgen
Labrys
Teva Pharma: Underpriced And Misunderstood, Identifiable Catalyst
Teva Pharma: Underpriced And Misunderstood, Identifiable Catalyst
Seeking Alpha
Teva Pharmaceuticals
[video]Supreme Court + Risky Drug Launch = Billions at Stake
[video]Supreme Court + Risky Drug Launch = Billions at Stake
Motley Fool
Supreme Court
Teva Pharmaceuticals
Copaxone
generics
MS
multiple sclerosis
Generic Copaxone approval very unlikely this quarter, says Jefferies
Generic Copaxone approval very unlikely this quarter, says Jefferies
The Fly on the Wall
generics
Copaxone
Teva Pharmaceuticals
MS
multiple sclerosis
Teva Doomsday Scenario Seen Averted as Patients Switch
Teva Doomsday Scenario Seen Averted as Patients Switch
Bloomberg
Teva Pharmaceuticals
Copaxone
Teva, Active Biotech to continue development of Nerventra
Teva, Active Biotech to continue development of Nerventra
The Fly on the Wall
Teva Pharmaceuticals
Nerventra
Active Biotech
MS
multiple sclerosis

Click here to subscribe to daily news headlines in your email inbox